Government

WHITE PAPERS AND CASE STUDIES

• How To Tackle Water Scarcity In A City Of 22 Million People

  Making Waves spoke with Bing Liu, Sales GM of Xylem’s Water Infrastructure business in China, about the country’s growing water reuse opportunity and one utility leader that is leading the way: Beijing Drainage Group.

• 4 Steps To Understanding The Quality Journey

  Explore a four-step framework for organizations to enhance quality management, emphasizing its importance in driving business success, customer satisfaction, and competitive advantage.

• From CLD To CDMO: Demonstrating A Successful Cell Line Technology Transfer

  Explore critical considerations for biopharmaceutical developers and CDMOs during technology transfer as well as a successful transfer and scale-up of a cell line from a CLD platform to a global CDMO.

• Cutting Costs, Not Corners: How PRI-TECH® Transformed Biosolids Odor Control At Bergen Point WWTP

  The Suffolk County Department of Public Works tested the effectiveness and cost-efficiency of PRI-TECH® in controlling odors at a wastewater treatment plant. The technology successfully treated odors and reduced operating costs.

• Building Trust Between Communities And Utilities

  This paper is a valuable resource for water utilities who want to upgrade their communications practices, so they can nurture better, lasting relationships with their customers. 

• Does Asset Health Monitoring Have A Role In The Water Sector?

  See why collaboration with trusted vendors is crucial for deploying reliable, adaptable, and sustainable asset health solutions in the evolving water sector.

• Strengthening Pathways For Cell And Gene Therapies

  This report aims to spur informed discussions on the future trajectory of cell and gene therapies and their pivotal role in shaping the future of healthcare.

• Placing Drug Strategies On A Solid Foundation For Success

  Explore how certain drivers are impacting traditional drug development strategies and relationships with outsourced drug development and manufacturing partners.

• Optimize Your Oncology Trial Protocol With Real-World Data

  Set your next oncological clinical trials up for success using high-quality real-world data (RWD) to anticipate and confront potential problems early on.

• Streamlining The Importing & Exporting Of Biological Samples

  Create a seamless and predictable import and export process by working with experienced bioanalytical laboratory partners, understanding what paperwork samples require, and proactive planning.

• Patient Diversity: Identifying Challenges, Opportunities, And Best Practices

  By listening to the voice of patient diversity and implementing FDA guidance measures, learn how stakeholders can improve trust, engagement, data reliability, patient outcomes, and promote public health.

• Boosting CMC Regulatory Efficiency In Gene Therapy

  Ensure your business stays ahead in today’s complex regulatory environment by implementing robust regulatory affairs strategies that streamline compliance and product approvals.